We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
+7.2%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
–
AUM
$378M
AUM Growth
+$40.8M
Cap. Flow
+$16.7M
Cap. Flow %
4.41%
Top 10 Hldgs %
63.44%
Holding
142
New
7
Increased
51
Reduced
65
Closed
3

Top Buys

Rank Stock Value
1
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$10.1M
2
SONY icon
Sony
SONY
+$3.72M
3
ADM icon
Archer Daniels Midland
ADM
+$1.22M
4
PFE icon
Pfizer
PFE
+$716K
5
AAPL icon
Apple
AAPL
+$532K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$617K
2
ABBV icon
AbbVie
ABBV
+$444K
3
MRK icon
Merck
MRK
+$409K
4
ECL icon
Ecolab
ECL
+$212K
5
A icon
Agilent Technologies
A
+$202K

Sector Composition

Rank Sector Weight
1 Technology 11.25%
2 Healthcare 10.5%
3 Consumer Staples 5.1%
4 Communication Services 3.11%
5 Materials 2.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
51
Walt Disney
DIS
$181B
$963K 0.25%
7,869
-766
-9% -$80K
DHR icon
52
Danaher
DHR
$144B
$947K 0.25%
3,793
-441
-10% -$108K
REGN icon
53
Regeneron Pharmaceuticals
REGN
$80.8B
$937K 0.25%
974
-90
-8% -$85.6K
J icon
54
Jacobs Solutions
J
$17B
$850K 0.22%
6,686
-119
-2% -$14K
VRTX icon
55
Vertex Pharmaceuticals
VRTX
$126B
$848K 0.22%
2,028
-236
-10% -$99.8K
HD icon
56
Home Depot
HD
$355B
$840K 0.22%
2,189
-186
-8% -$68K
T icon
57
AT&T
T
$163B
$804K 0.21%
45,671
+683
+2% +$11.7K
JPM icon
58
JPMorgan Chase
JPM
$950B
$758K 0.2%
3,786
-293
-7% -$52.9K
HPQ icon
59
HP
HPQ
$27.5B
$751K 0.2%
24,835
+1,523
+7% +$44.8K
MRNA icon
60
Moderna
MRNA
$23.6B
$748K 0.2%
7,023
-613
-8% -$61.8K
BSX icon
61
Boston Scientific
BSX
$71.5B
$730K 0.19%
10,665
-1,354
-11% -$87.1K
LH icon
62
Labcorp
LH
$25.9B
$727K 0.19%
3,330
+174
+6% +$38.3K
MET icon
63
MetLife
MET
$62.1B
$685K 0.18%
9,243
-181
-2% -$12.6K
ELV icon
64
Elevance Health
ELV
$85.5B
$681K 0.18%
1,314
-20
-1% -$9.95K
DGX icon
65
Quest Diagnostics
DGX
$26.3B
$670K 0.18%
5,031
+730
+17% +$94.7K
CI icon
66
Cigna
CI
$74.6B
$651K 0.17%
1,793
-208
-10% -$68.5K
MCK icon
67
McKesson
MCK
$101B
$628K 0.17%
1,170
-46
-4% -$23.4K
IBB icon
68
iShares Biotechnology ETF
IBB
$9.77B
$617K 0.16%
4,500
– –
RWX icon
69
State Street SPDR Dow Jones International Real Estate ETF
RWX
$270M
$600K 0.16%
23,000
– –
TMUS icon
70
T-Mobile US
TMUS
$190B
$570K 0.15%
3,490
-1
-0% -$163
GIS icon
71
General Mills
GIS
$19.7B
$551K 0.15%
7,881
+664
+9% +$43.2K
BAX icon
72
Baxter International
BAX
$14.2B
$543K 0.14%
12,713
-1,032
-8% -$42K
LOW icon
73
Lowe's Companies
LOW
$125B
$536K 0.14%
2,105
-52
-2% -$12K
DD icon
74
DuPont de Nemours
DD
$19.2B
$534K 0.14%
5,546
+599
+12% +$53.3K
DELL icon
75
Dell
DELL
$293B
$529K 0.14%
4,638
-260
-5% -$24.3K
1 2
3
4 5

Similar funds

MWM
Momentous Wealth Management Vancouver, Washington $175M AUM 14.91% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $175M AUM 21.91% 1-Year Est. Return
CC
Converium Capital Montreal $175M AUM
BW
Basepoint Wealth Cedar Rapids, Iowa $175M AUM 43.04% 1-Year Est. Return
DWA
Delos Wealth Advisors Dallas, Texas $175M AUM 19.35% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Humankind Investments's Q1 2024 Portfolio in Review

As of Q1 2024, Humankind Investments held 142 positions worth $378M, up 12% from $337M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Humankind Investments deployed $16.7M of net new capital in Q1 2024, opening 7 new positions and adding to 51 existing holdings. Its largest new stake was Sony: 202,195 shares worth $3.47M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Eli Lilly, an estimated $617K trimmed.

  • Humankind Investments's largest Q1 2024 buy was Sony: 202,195 shares worth $3.47M.
  • Humankind Investments added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2024, an estimated $10.1M increase.
  • Humankind Investments's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $617K.
  • Humankind Investments fully exited Agilent Technologies in Q1 2024, selling an estimated $202K.
  • Humankind Investments's ten largest holdings make up 63% of its $378M portfolio in Q1 2024.
  • Humankind Investments opened 7 new positions and closed 3 in Q1 2024.
  • Humankind Investments's portfolio value rose 12% quarter-over-quarter to $378M.

Based on Humankind Investments's 13F filing for Q1 2024, filed 8 May 2024.